FIELD: biotechnology.
SUBSTANCE: Staphylococcus aureus strain SA0077 dap and Staphylococcus aureus A dap/40 strain, which have a high level of resistance to daptomycin, were deposited in the State Collection of Pathogenic Microorganisms and Cell Cultures under registration numbers B-9988 and B-9983, respectively (variants).
EFFECT: inventions provide an expansion of the arsenal of tools used as a control test culture to determine sensitivity to lipopeptide antibiotics.
2 cl, 3 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STAPHYLOCOCCUS AUREUS STRAINS CHARACTERIZED BY RESISTANCE TO VANCOMYCIN AND USED AS CONTROL TEST CULTURES FOR DETERMINING SENSITIVITY TO GLYCOPEPTIDE ANTIBIOTICS | 2022 |
|
RU2802896C1 |
| STAPHYLOCOCCUS AUREUS A9 STRAIN CHARACTERIZED BY TOLERANCE TO CIPROFLOXACIN AND USED AS CONTROL TEST CULTURE TO DETERMINE SENSITIVITY TO ANTIBIOTICS | 2022 |
|
RU2809538C1 |
| STRAIN OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) CHARACTERIZED BY RESISTANCE TO CEFTAROLINE AND USED AS A CONTROL TEST CULTURE TO DETERMINE SENSITIVITY TO BETA-LACTAM ANTIBIOTICS (VARIANTS) | 2022 |
|
RU2798788C1 |
| STRAINS OF STAPHYLOCOCCUS AUREUS (MSSA) CHARACTERIZED BY MEC-INDEPENDENT MECHANISMS OF RESISTANCE TO BETA-LACTAMS AND USED AS CONTROL TEST CULTURES TO DETERMINE THE SENSITIVITY TO BETA-LACTAM ANTIBIOTICS | 2022 |
|
RU2802895C1 |
| COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
| BIOFILM PREVENTION, DESTRUCTION AND TREATMENT BY BACTERIOPHAGE LYSIN | 2013 |
|
RU2646102C2 |
| PREVENTION, DESTRUCTION AND TREATMENT OF BIOFILM BY BACTERIOPHAGE LYSINE | 2013 |
|
RU2735103C2 |
| METHOD FOR OVERCOMING GENTAMYCIN RESISTANCE IN METHICILLIN-RESISTANT S. AUREUS STRAINS | 2013 |
|
RU2553601C2 |
| METHOD FOR MICRO-DILUTION IN LIQUID MEDIUM FOR EVALUATING AND DETERMINING MINIMUM INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | 2017 |
|
RU2754667C2 |
| METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2666605C2 |
